πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

325 results for β€œDisc” Clear

  1. Levosimendan Kalceks 2,5Β mg/ml concentraat voor oplossing voor infusie, Soluvit N poeder voor oplossing voor intraveneuze infusie

    Disc Medicine

    Failure to wean from invasive ventilation.

    approved small molecule active

    1 trial

  2. MEPOLIZUMAB

    Disc Medicine

    Eosinophilic Granulomatosis with Polyangiitis (eGPA)

    approved small molecule active

    1 trial

  3. METHADONE , Suboxone 2 mg/0.5 mg sublingual tablets

    Disc Medicine

    Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).

    approved small molecule active

    1 trial

  4. METHOTREXATE, METHOTREXATE, PREDNISONE, METHOTREXATE

    Disc Medicine

    Pulmonary sarcoidosis

    approved small molecule active

    1 trial

  5. MORPHINE , EDOXABAN , ENZALUTAMIDE

    Disc Medicine

    Prostate cancer

    approved small molecule active

    1 trial

  6. Methotrexate 2,5 mg film-coated tablets, Simponi 50 mg solution for injection in pre-filled syringe., Hydroxychloroquine sulfate 200mg film-coated Tablets, Cimzia 200 mg solution for injection in pre-filled syringe, Depo-Medrol 80 mg/2 ml Injektionssuspension, Leflunomide Aurobindo 20 mg compresse rivestite con film, Enbrel 50 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe, Sulfasalazine 500 mg Tablets, Jyseleca 200 mg film-coated tablets, Kenacort

    Disc Medicine

    Rheumatoid arthritis according to 2010 criteria

    approved small molecule active

    1 trial

  7. Myozyme 50 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease / glycogenosis type II / acid maltase deficiency

    approved small molecule active

    1 trial

  8. Myozyme 50 mg powder for concentrate for solution for infusion, Opfolda 65 mg hard capsules, Pombiliti 105 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease

    approved small molecule active

    1 trial

  9. Mysimba 8 mg/90 mg prolonged-release tablets

    Disc Medicine

    Obesity, Obesity Surgery

    approved small molecule active

    1 trial

  10. NIVOLUMAB

    Disc Medicine

    Melanoma, Renal cell carcinoma

    approved small molecule active

    1 trial

  11. Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Glycogen storage disease type II or acid maltase deficiency, Pompe disease

    approved small molecule active

    1 trial

  12. OXALIPLATIN, CAPECITABINE

    Disc Medicine

    Locally advanced or metastatic gastro-intestinal carcinoma

    approved small molecule active

    1 trial

  13. Ozempic 1 mg solution for injection in pre-filled pen, Ozempic 0.5 mg solution for injection in pre-filled pen, Ozempic 2 mg solution for injection in pre-filled pen, Ozempic 0.25 mg solution for injection in pre-filled pen

    Disc Medicine

    Diabetic foot ulcer

    approved small molecule active

    1 trial

  14. PALEXIA Retard 50 mg tabletten met verlengde afgifte

    Disc Medicine

    chronic postoperative pain

    approved small molecule active

    1 trial

  15. PEMBROLIZUMAB , NIVOLUMAB , IPILIMUMAB

    Disc Medicine

    Melanoma

    approved small molecule active

    1 trial

  16. PREDNISONE, MYCOPHENOLATE MOFETIL, TACROLIMUS

    Disc Medicine

    kidney transplantation

    approved small molecule active

    1 trial

  17. PROGRAF 1 mg capsule, Modigraf 0.2 mg granules for oral suspension, Envarsus 0.75 mg prolonged-release tablets, PROGRAF 0,5 mg capsule, Envarsus 4 mg prolonged-release tablets, Envarsus 1 mg prolonged-release tablets, PROGRAF 5 mg capsule, Modigraf 1 mg granules for oral suspension

    Disc Medicine

    pediatric kidney transplant recipients

    approved small molecule active

    1 trial

  18. Pantoprazole Teva 40 mg maagsapresistente tabletten, Mycophenolate mofetil Sandoz 500 mg Film-coated Tablets, Mycophenolate Mofetil Accord 500 mg plΔ—vele dengtos tabletΔ—s, CellCept 500 mg film-coated tablets

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial

  19. Pioglitazone and Metformin

    Disc Medicine

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  20. Placebo of rosuvastatin 10mg (tablet) as produced by Apotheek A15, Rosuvastatin tablet 10mg Apotheek A15

    Disc Medicine

    Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)

    approved small molecule active

    1 trial

  21. Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 Β°C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial

  22. Placebo: PL1, Pharmaceutical form: Capsule, Route of administration: Oral use, Hydrocortison DMB 20 mg, tabletten

    Disc Medicine

    Posttraumatic Stress Disorder (PTSD)

    approved small molecule active

    1 trial

  23. Plavix 75 mg film-coated tablets, Clopidogrel Viatris 75 mg film-coated tablets, ACETYLSALICYLIC ACID , DIPYRIDAMOLE

    Disc Medicine

    Stroke

    approved small molecule active

    1 trial

  24. Pneumovax 23, oplossing voor injectie in een voorgevulde spuit Pneumokokkenpolysacharidevaccin

    Disc Medicine

    Vaccination response

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources